Stay updated on Extension Study for KarXT Safety in Schizophrenia Clinical Trial
Sign up to get notified when there's something new on the Extension Study for KarXT Safety in Schizophrenia Clinical Trial page.
![Latest website image capture](/pages/_next/image?url=https%3A%2F%2Fs3.us-west-2.amazonaws.com%2Fvp-files-ore%2Fresources%2F12months%2FHAre-unyjjxzDmpgjBGRNM3C_3Y.uncropped.jpg&w=3840&q=75)
Latest updates to the Extension Study for KarXT Safety in Schizophrenia Clinical Trial page
- Check7 days agoChange DetectedA new study has been added with 152 Tokyo locations, including a specific site in Shibuya-ku, while a previous study with 151 locations and FDA safety alerts has been removed.SummaryDifference0.7%
- Check14 days agoChange DetectedThe study count has increased to 151 with a new location added in Toyoake, Aichi, Japan, while the previous study count of 150 has been removed.SummaryDifference0.8%
- Check21 days agoChange DetectedThe website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements.SummaryDifference0.0%
- Check28 days agoChange DetectedThe website has added a new section for BMS Clinical Trial Patient Recruiting.SummaryDifference0.1%
- Check35 days agoChange DetectedThe website has updated the 'Last Update Posted' information, removing the 'Estimated' qualifier.SummaryDifference0.0%
- Check36 days agoChange DetectedThe website has added extensive contact information for various study sites and updated the recruiting status, while removing previous enrollment details and dates.SummaryDifference35%
Stay in the know with updates to Extension Study for KarXT Safety in Schizophrenia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Extension Study for KarXT Safety in Schizophrenia Clinical Trial page.